Tavelmout Biofarm

Tavelmout Biofarm (TVMB), a Bruneian subsidiary of Tabérumo Corporation — a pioneer in the large-scale cultivation of spirulina using photobioreactors — has launched their spirulina production facility at Darussalam Enterprise Bio-Innovation Corridor Industrial Park situated in Kampong Tungku-Rimba, in Brunei.

With the launch, TVMB has introduced their locally produced Tabérumo product. TVMB claims that Tabérumo is the world’s first frozen raw spirulina that satisfies Japanese rigorous and stringent food safety standards. It is sold mainly in Japanese markets by TVMB’s parent company Tabérumo Corp. Although the company’s initial target market is Japan, they are also aiming to expand to other overseas markets, including the booming global Halal market, after the approval of certification from Brunei.

Tabérumo Corp. is one business entity of a group of biotech companies known as the Chitose Group — a group of biotechnology startups (11 in total as of the end of September 2019) that mainly operates in Japan and Southeast Asia “in order to leave humankind a prosperous environment to live for over a thousand years.” Odorless, fresh tasting raw spirulina are produced and commercialized by the group using the cultivation technologies developed by Chitose Laboratory Corp., which is the research entity of the Chitose Group.

Brunei possesses stable and warm temperatures, rich freshwater resources, and access to surrounding global markets, but the land suitable for conventional crop production is limited. TVMB recognizes that these conditions allow for stable, high-quality-yielding, economic, and more sustainable production of spirulina and, according to the company, will allow them to assume a leadership role in filling the gap of the pending food/protein demands of the world in the near future.


Tabérumo produced in the new Tavelmout Biofarm facility will begin its commercialization in Japan by the end of this year.

TVMB is targeting to produce six tons of spirulina per month initially, increasing the production capacity yearly, with maximum production volume after expansion of the facility expected to reach 1,000 tons.

The new Brunei facility was financed by Innovation Network Corporation of Japan (INCJ) and Mitsubishi Corporation (MC) through the acceptance of a third-party allocation of shares by Tavelmout. The total investment amounts to 1.7 billion yen (1.6 million USD), evenly split between INCJ and MC.